BioPharmSignal logoBioPharmSignal

Biotech News

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

Outset Medical (OM)Outset MedicalFDA / regulatory

Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standards SAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less

Related news

SGHTSight Sciences2026-08-04 21:38 EST

Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System

HYPRHyperfine2026-08-20 12:15 EST

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

ADPTAdaptive Biotechnologies2026-06-30 12:30 EST

Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial

ANGOAngioDynamics2026-06-17 12:30 EST

AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)

OMOutset Medical2026-08-06 20:01 EST

Outset Medical Reports Second Quarter 2026 Results

OMOutset Medical2026-07-23 13:00 EST

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

ICCMIceCure Medical2026-06-17 12:25 EST

IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance

ICCMIceCure Medical2026-07-29 12:25 EST

IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®

FEMYFEMASYS2026-08-19 13:00 EST

Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®

AORTArtivion2026-06-29 11:00 EST

Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

View all latest news

Outset Medical

Dialysis Technology Outset Medical develops technology intended to simplify dialysis delivery across hospitals, clinics and home-care settings. Tablo Hemodialysis System Tablo is an integrated hemodialysis system that combines water purification, on-demand dialysate production and treatment delivery in a single device. Its design seeks...

Recent company news

OMOutset Medical2026-08-06 20:01 EST

Outset Medical Reports Second Quarter 2026 Results

OMOutset Medical2026-07-23 13:00 EST

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

OMOutset Medical2026-07-02 20:05 EST

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-05-21 20:05 EST

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-05-11 20:05 EST

Outset Medical to Present at RBC Global Healthcare Conference

Stock data

Close
4.21 USD
Market cap
93.98M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States